An adverse outcome is still encountered in 45% of full-term neonates with perinatal asphyxia
who are treated with moderate hypothermia. At present pharmacologic therapies are …

Neonatal hypoxic-ischemic encephalopathy is a disorder with heterogeneous manifestation
due to asphyxia during perinatal period. It affects approximately 3–12 children per 1000 live …

During the past decade, accumulating evidence from both clinical and experimental studies
has indicated that erythropoietin may have antidepressant effects. In addition to the kidney …

Erythropoietin (EPO), essential for erythropoiesis, provides neuroprotection. The EPO
receptor (EPOR) is expressed in both neural and non-neural cells in the brain. This study …

The hippocampus is often injured in neonatal stroke. We have investigated the effect of
erythropoietin (EPO) on oxygen-glucose deprived hippocampal slices and hypoxic …

The protective effects of recombinant human lactoferrin rhLF (branded “CAPRABEL™”) on
the cognitive functions of rat offspring subjected to prenatal hypoxia (7% O2, 3 h, 14th day of …

There are mixed reports on the neuroprotective properties of erythropoietin (EPO) in animal
models of birth asphyxia. We investigated the effect of EPO on short-and long-term outcome …

Introduction Anemia is common after subarachnoid hemorrhage (SAH) and may exacerbate
the reduction in oxygen delivery that underlies delayed cerebral ischemia. Fall in …

Our previous clinical studies demonstrated the synergistic therapeutic effect induced by co-
administering recombinant human erythropoietin (rhEPO) in human umbilical cord blood …

The kidney is a vital organ that carries out significant metabolic functions in our body. Due to
the complexity of its role, the kidney is also susceptible to many disease conditions, such as …